Fingerprint Fingerprint is based on mining the text of the persons scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 15 Similar Profiles
gemcitabine Medicine & Life Sciences
Pancreatic Neoplasms Medicine & Life Sciences
Sarcoma Medicine & Life Sciences
Radiotherapy Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
oxaliplatin Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Fluorouracil Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 1997 2021

Research Output 1988 2018

  • 4342 Citations
  • 37 h-Index
  • 119 Article
  • 9 Review article
  • 2 Comment/debate
  • 2 Letter
2 Citations

A Phase 2 Randomized, Double-Blind, Multicenter Trial of Imexon Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients with Metastatic Chemotherapy-naïve Pancreatic Adenocarcinoma

Cohen, S. J., Zalupski, M. M., Conkling, P., Nugent, F., Ma, W. W., Modiano, M., Pascual, R., Lee, F. C., Wong, L. & Hersh, E. Jan 1 2018 In : American Journal of Clinical Oncology: Cancer Clinical Trials. 41, 3, p. 230-235 6 p.

Research output: Contribution to journalArticle

gemcitabine
Multicenter Studies
Adenocarcinoma
Placebos
Drug Therapy

A Phase II Study of Biweekly Cisplatin, Fixed-Dose-Rate Gemcitabine and Infusional 5-Fluorouracil in Patients With Metastatic Pancreatic and Biliary Cancers

Davis, E. J., Griffith, K. A., Kim, E. J., Ruch, J. M., McDonnell, K. J. & Zalupski, M. M. Jan 1 2018 In : American Journal of Clinical Oncology: Cancer Clinical Trials. 41, 2, p. 128-132 5 p.

Research output: Contribution to journalArticle

gemcitabine
Biliary Tract Neoplasms
Pancreatic Neoplasms
Fluorouracil
Cisplatin

HALO 202: Randomized phase II Study of PEGPH20 Plus Nab-Paclitaxel/Gemcitabine Versus Nab-Paclitaxel/Gemcitabine in Patients With Untreated, Metastatic Pancreatic Ductal Adenocarcinoma

Hingorani, S. R., Zheng, L., Bullock, A. J., Seery, T. E., Harris, W. P., Sigal, D. S., Braiteh, F., Ritch, P. S., Zalupski, M. M., Bahary, N., Oberstein, P. E., Wang-Gillam, A., Wu, W., Chondros, D., Jiang, P., Khelifa, S., Pu, J., Aldrich, C. & Hendifar, A. E. Feb 1 2018 In : Journal of Clinical Oncology. 36, 4, p. 359-366 8 p.

Research output: Contribution to journalArticle

gemcitabine
Hyaluronic Acid
Adenocarcinoma
Paclitaxel
Enoxaparin
irinotecan
Dysarthria
Neoplasms
Topoisomerase I Inhibitors
Neoadjuvant Therapy
Pancreatic Neoplasms
therapy
cancer
Thymidylate Synthase